Katherine Owens

8PUBLICATIONS
15CO-AUTHORS
Infectious diseasesCancer therapy (excl. chemotherapy and radiation therapy)Medical virologyNanotoxicology, health and safetyNeurology and neuromuscular diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 06, 2026
Is it "time to eliminate" time to elimination of symptoms as a primary trial endpoint for respiratory virus targeting drugs?

Joshua T Schiffer, Shadisadat Esmaeili, Katherine Owens

|Jun 03, 2025
Spatiotemporal dynamics of tumor-CAR T-cell interaction following local administration in solid cancers.

Katherine Owens, Aminur Rahman, Ivana Bozic

|Jan 20, 2025
Molnupiravir clinical trial simulation suggests that polymerase chain reaction underestimates antiviral potency against SARS-CoV-2.

Shadisadat Esmaeili, Katherine Owens, Joseph F Standing

|Sep 11, 2024
Spatiotemporal dynamics of tumor - CAR T-cell interaction following local administration in solid cancers.

Katherine Owens, Aminur Rahman, Ivana Bozic

|Jun 28, 2024
A unifying model to explain frequent SARS-CoV-2 rebound after nirmatrelvir treatment and limited prophylactic efficacy.

Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner

|Feb 14, 2024
A unifying model to explain high nirmatrelvir therapeutic efficacy against SARS-CoV-2, despite low post-exposure prophylaxis efficacy and frequent viral rebound.

Shadisadat Esmaeili, Katherine Owens, Jessica Wagoner

Pageof 2